879 related articles for article (PubMed ID: 34303328)
41. Tumor-associated macrophages: implications in cancer immunotherapy.
Petty AJ; Yang Y
Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
[TBL] [Abstract][Full Text] [Related]
42. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
[TBL] [Abstract][Full Text] [Related]
43. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
[TBL] [Abstract][Full Text] [Related]
44. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
[TBL] [Abstract][Full Text] [Related]
45. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
46. Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway.
Jang H; Ojha U; Jeong JH; Park KG; Lee SY; Lee YM
Arch Pharm Res; 2023 Jul; 46(7):629-645. PubMed ID: 37468765
[TBL] [Abstract][Full Text] [Related]
47. Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
Zhang J; Dong Y; Di S; Xie S; Fan B; Gong T
Biomed Pharmacother; 2023 Nov; 167():115610. PubMed ID: 37783153
[TBL] [Abstract][Full Text] [Related]
48. Targeting tumor associated macrophages in hepatocellular carcinoma.
Xu W; Cheng Y; Guo Y; Yao W; Qian H
Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
[TBL] [Abstract][Full Text] [Related]
49. Macrophage Polarization States in the Tumor Microenvironment.
Boutilier AJ; Elsawa SF
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
[TBL] [Abstract][Full Text] [Related]
50. Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment.
He Z; Zhang S
Front Immunol; 2021; 12():741305. PubMed ID: 34603327
[TBL] [Abstract][Full Text] [Related]
51. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.
Zhu L; Li XJ; Gangadaran P; Jing X; Ahn BC
Cancer Immunol Immunother; 2023 Dec; 72(12):3895-3917. PubMed ID: 37796300
[TBL] [Abstract][Full Text] [Related]
52. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
Zins K; Abraham D
Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
[TBL] [Abstract][Full Text] [Related]
53. Tumor-associated macrophages in osteosarcoma.
Zhao Y; Zhang B; Zhang Q; Ma X; Feng H
J Zhejiang Univ Sci B; 2021 Nov; 22(11):885-892. PubMed ID: 34783219
[TBL] [Abstract][Full Text] [Related]
54. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
55. miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
Zhou H; Gan M; Jin X; Dai M; Wang Y; Lei Y; Lin Z; Ming J
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069230
[TBL] [Abstract][Full Text] [Related]
56. In vitro functional assays to assess the reciprocal interplay between tumor cells and macrophages.
Karimova AF; Ketkar A; Suezov R; Khalitova AR; Gomzikova M; Mukhamedshina Y; Lauth M; Huber M; Simon HU; Brichkina A
FASEB J; 2024 Jul; 38(13):e23730. PubMed ID: 38900063
[TBL] [Abstract][Full Text] [Related]
57. [Research progress on tumor-associated macrophages in colorectal cancer].
Huang S; Li F; Jin D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):940-945. PubMed ID: 37882718
[TBL] [Abstract][Full Text] [Related]
58. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
Hou S; Zhao Y; Chen J; Lin Y; Qi X
J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
[TBL] [Abstract][Full Text] [Related]
59. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.
Cheng N; Bei Y; Song Y; Zhang W; Xu L; Zhang W; Yang N; Bai X; Shu Y; Shen P
Biochem Pharmacol; 2021 Jan; 183():114298. PubMed ID: 33153969
[TBL] [Abstract][Full Text] [Related]
60. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
